Global Swine Mycoplasma Pneumonia Live Vaccine Market Growth 2026-2032
The global Swine Mycoplasma Pneumonia Live Vaccine market size is predicted to grow from US$ 256 million in 2025 to US$ 393 million in 2032; it is expected to grow at a CAGR of 6.4% from 2026 to 2032.
Swine Mycoplasma Pneumonia Live Vaccine is a vaccine used to prevent respiratory diseases caused by Mycoplasma hyopneumoniae in pigs. This vaccine is a live attenuated vaccine that helps to stimulate the pig's immune system to recognize and fight against the bacteria that causes pneumonia.
United States market for Swine Mycoplasma Pneumonia Live Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Swine Mycoplasma Pneumonia Live Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Swine Mycoplasma Pneumonia Live Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Swine Mycoplasma Pneumonia Live Vaccine players cover Zoetis, Boehringer Ingelheim, Merck, HIPRA, Ceva Sant? Animale, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Swine Mycoplasma Pneumonia Live Vaccine Industry Forecast” looks at past sales and reviews total world Swine Mycoplasma Pneumonia Live Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Swine Mycoplasma Pneumonia Live Vaccine sales for 2026 through 2032. With Swine Mycoplasma Pneumonia Live Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Swine Mycoplasma Pneumonia Live Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Swine Mycoplasma Pneumonia Live Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Swine Mycoplasma Pneumonia Live Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Swine Mycoplasma Pneumonia Live Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Swine Mycoplasma Pneumonia Live Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Swine Mycoplasma Pneumonia Live Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Swine Mycoplasma Pneumonia Live Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Swine Mycoplasma Pneumonia Live Vaccine market?
What factors are driving Swine Mycoplasma Pneumonia Live Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Swine Mycoplasma Pneumonia Live Vaccine market opportunities vary by end market size?
How does Swine Mycoplasma Pneumonia Live Vaccine break out by Type, by Application?
Swine Mycoplasma Pneumonia Live Vaccine is a vaccine used to prevent respiratory diseases caused by Mycoplasma hyopneumoniae in pigs. This vaccine is a live attenuated vaccine that helps to stimulate the pig's immune system to recognize and fight against the bacteria that causes pneumonia.
United States market for Swine Mycoplasma Pneumonia Live Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Swine Mycoplasma Pneumonia Live Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Swine Mycoplasma Pneumonia Live Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Swine Mycoplasma Pneumonia Live Vaccine players cover Zoetis, Boehringer Ingelheim, Merck, HIPRA, Ceva Sant? Animale, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Swine Mycoplasma Pneumonia Live Vaccine Industry Forecast” looks at past sales and reviews total world Swine Mycoplasma Pneumonia Live Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Swine Mycoplasma Pneumonia Live Vaccine sales for 2026 through 2032. With Swine Mycoplasma Pneumonia Live Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Swine Mycoplasma Pneumonia Live Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Swine Mycoplasma Pneumonia Live Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Swine Mycoplasma Pneumonia Live Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Swine Mycoplasma Pneumonia Live Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Swine Mycoplasma Pneumonia Live Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Swine Mycoplasma Pneumonia Live Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Swine Mycoplasma Pneumonia Live Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 168 Strains
- RM48 Strains
- Other
- Piglets
- Adult Pigs
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Zoetis
- Boehringer Ingelheim
- Merck
- HIPRA
- Ceva Sant? Animale
- Harbin Pharmaceutical Group
- Qilu Animal Health Products
- Guangdong Winsun Bio-Pharmaceutical
- Jilin HeYuan Bioengineering
- Jofunhwa Biotechnology
What is the 10-year outlook for the global Swine Mycoplasma Pneumonia Live Vaccine market?
What factors are driving Swine Mycoplasma Pneumonia Live Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Swine Mycoplasma Pneumonia Live Vaccine market opportunities vary by end market size?
How does Swine Mycoplasma Pneumonia Live Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Swine Mycoplasma Pneumonia Live Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Swine Mycoplasma Pneumonia Live Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Swine Mycoplasma Pneumonia Live Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Swine Mycoplasma Pneumonia Live Vaccine Segment by Type
2.2.1 168 Strains
2.2.2 RM48 Strains
2.2.3 Other
2.2.4 Swine Mycoplasma Pneumonia Live Vaccine Sales by Type
2.2.4.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Type (2021-2026)
2.2.4.2 Global Swine Mycoplasma Pneumonia Live Vaccine Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sale Price by Type (2021-2026)
2.3 Swine Mycoplasma Pneumonia Live Vaccine Segment by Application
2.3.1 Piglets
2.3.2 Adult Pigs
2.3.3 Swine Mycoplasma Pneumonia Live Vaccine Sales by Application
2.3.3.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Swine Mycoplasma Pneumonia Live Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Swine Mycoplasma Pneumonia Live Vaccine Breakdown Data by Company
3.1.1 Global Swine Mycoplasma Pneumonia Live Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Swine Mycoplasma Pneumonia Live Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Company (2021-2026)
3.2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sale Price by Company
3.4 Key Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Product Location Distribution
3.4.2 Players Swine Mycoplasma Pneumonia Live Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SWINE MYCOPLASMA PNEUMONIA LIVE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Swine Mycoplasma Pneumonia Live Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Swine Mycoplasma Pneumonia Live Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Swine Mycoplasma Pneumonia Live Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Swine Mycoplasma Pneumonia Live Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Swine Mycoplasma Pneumonia Live Vaccine Sales Growth
4.4 APAC Swine Mycoplasma Pneumonia Live Vaccine Sales Growth
4.5 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Growth
4.6 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Growth
5 AMERICAS
5.1 Americas Swine Mycoplasma Pneumonia Live Vaccine Sales by Country
5.1.1 Americas Swine Mycoplasma Pneumonia Live Vaccine Sales by Country (2021-2026)
5.1.2 Americas Swine Mycoplasma Pneumonia Live Vaccine Revenue by Country (2021-2026)
5.2 Americas Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2021-2026)
5.3 Americas Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Swine Mycoplasma Pneumonia Live Vaccine Sales by Region
6.1.1 APAC Swine Mycoplasma Pneumonia Live Vaccine Sales by Region (2021-2026)
6.1.2 APAC Swine Mycoplasma Pneumonia Live Vaccine Revenue by Region (2021-2026)
6.2 APAC Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2021-2026)
6.3 APAC Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Swine Mycoplasma Pneumonia Live Vaccine by Country
7.1.1 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales by Country (2021-2026)
7.1.2 Europe Swine Mycoplasma Pneumonia Live Vaccine Revenue by Country (2021-2026)
7.2 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2021-2026)
7.3 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine by Country
8.1.1 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Swine Mycoplasma Pneumonia Live Vaccine
10.3 Manufacturing Process Analysis of Swine Mycoplasma Pneumonia Live Vaccine
10.4 Industry Chain Structure of Swine Mycoplasma Pneumonia Live Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Swine Mycoplasma Pneumonia Live Vaccine Distributors
11.3 Swine Mycoplasma Pneumonia Live Vaccine Customer
12 WORLD FORECAST REVIEW FOR SWINE MYCOPLASMA PNEUMONIA LIVE VACCINE BY GEOGRAPHIC REGION
12.1 Global Swine Mycoplasma Pneumonia Live Vaccine Market Size Forecast by Region
12.1.1 Global Swine Mycoplasma Pneumonia Live Vaccine Forecast by Region (2027-2032)
12.1.2 Global Swine Mycoplasma Pneumonia Live Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Swine Mycoplasma Pneumonia Live Vaccine Forecast by Type (2027-2032)
12.7 Global Swine Mycoplasma Pneumonia Live Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
13.1.3 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
13.3.3 Merck Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 HIPRA
13.4.1 HIPRA Company Information
13.4.2 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
13.4.3 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 HIPRA Main Business Overview
13.4.5 HIPRA Latest Developments
13.5 Ceva Sant? Animale
13.5.1 Ceva Sant? Animale Company Information
13.5.2 Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
13.5.3 Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Ceva Sant? Animale Main Business Overview
13.5.5 Ceva Sant? Animale Latest Developments
13.6 Harbin Pharmaceutical Group
13.6.1 Harbin Pharmaceutical Group Company Information
13.6.2 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
13.6.3 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Harbin Pharmaceutical Group Main Business Overview
13.6.5 Harbin Pharmaceutical Group Latest Developments
13.7 Qilu Animal Health Products
13.7.1 Qilu Animal Health Products Company Information
13.7.2 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
13.7.3 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Qilu Animal Health Products Main Business Overview
13.7.5 Qilu Animal Health Products Latest Developments
13.8 Guangdong Winsun Bio-Pharmaceutical
13.8.1 Guangdong Winsun Bio-Pharmaceutical Company Information
13.8.2 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
13.8.3 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Guangdong Winsun Bio-Pharmaceutical Main Business Overview
13.8.5 Guangdong Winsun Bio-Pharmaceutical Latest Developments
13.9 Jilin HeYuan Bioengineering
13.9.1 Jilin HeYuan Bioengineering Company Information
13.9.2 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
13.9.3 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Jilin HeYuan Bioengineering Main Business Overview
13.9.5 Jilin HeYuan Bioengineering Latest Developments
13.10 Jofunhwa Biotechnology
13.10.1 Jofunhwa Biotechnology Company Information
13.10.2 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
13.10.3 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Jofunhwa Biotechnology Main Business Overview
13.10.5 Jofunhwa Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Swine Mycoplasma Pneumonia Live Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Swine Mycoplasma Pneumonia Live Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Swine Mycoplasma Pneumonia Live Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Swine Mycoplasma Pneumonia Live Vaccine Segment by Type
2.2.1 168 Strains
2.2.2 RM48 Strains
2.2.3 Other
2.2.4 Swine Mycoplasma Pneumonia Live Vaccine Sales by Type
2.2.4.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Type (2021-2026)
2.2.4.2 Global Swine Mycoplasma Pneumonia Live Vaccine Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sale Price by Type (2021-2026)
2.3 Swine Mycoplasma Pneumonia Live Vaccine Segment by Application
2.3.1 Piglets
2.3.2 Adult Pigs
2.3.3 Swine Mycoplasma Pneumonia Live Vaccine Sales by Application
2.3.3.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Swine Mycoplasma Pneumonia Live Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Swine Mycoplasma Pneumonia Live Vaccine Breakdown Data by Company
3.1.1 Global Swine Mycoplasma Pneumonia Live Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Swine Mycoplasma Pneumonia Live Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Company (2021-2026)
3.2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sale Price by Company
3.4 Key Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Product Location Distribution
3.4.2 Players Swine Mycoplasma Pneumonia Live Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SWINE MYCOPLASMA PNEUMONIA LIVE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Swine Mycoplasma Pneumonia Live Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Swine Mycoplasma Pneumonia Live Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Swine Mycoplasma Pneumonia Live Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Swine Mycoplasma Pneumonia Live Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Swine Mycoplasma Pneumonia Live Vaccine Sales Growth
4.4 APAC Swine Mycoplasma Pneumonia Live Vaccine Sales Growth
4.5 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Growth
4.6 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Growth
5 AMERICAS
5.1 Americas Swine Mycoplasma Pneumonia Live Vaccine Sales by Country
5.1.1 Americas Swine Mycoplasma Pneumonia Live Vaccine Sales by Country (2021-2026)
5.1.2 Americas Swine Mycoplasma Pneumonia Live Vaccine Revenue by Country (2021-2026)
5.2 Americas Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2021-2026)
5.3 Americas Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Swine Mycoplasma Pneumonia Live Vaccine Sales by Region
6.1.1 APAC Swine Mycoplasma Pneumonia Live Vaccine Sales by Region (2021-2026)
6.1.2 APAC Swine Mycoplasma Pneumonia Live Vaccine Revenue by Region (2021-2026)
6.2 APAC Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2021-2026)
6.3 APAC Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Swine Mycoplasma Pneumonia Live Vaccine by Country
7.1.1 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales by Country (2021-2026)
7.1.2 Europe Swine Mycoplasma Pneumonia Live Vaccine Revenue by Country (2021-2026)
7.2 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2021-2026)
7.3 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine by Country
8.1.1 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Swine Mycoplasma Pneumonia Live Vaccine
10.3 Manufacturing Process Analysis of Swine Mycoplasma Pneumonia Live Vaccine
10.4 Industry Chain Structure of Swine Mycoplasma Pneumonia Live Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Swine Mycoplasma Pneumonia Live Vaccine Distributors
11.3 Swine Mycoplasma Pneumonia Live Vaccine Customer
12 WORLD FORECAST REVIEW FOR SWINE MYCOPLASMA PNEUMONIA LIVE VACCINE BY GEOGRAPHIC REGION
12.1 Global Swine Mycoplasma Pneumonia Live Vaccine Market Size Forecast by Region
12.1.1 Global Swine Mycoplasma Pneumonia Live Vaccine Forecast by Region (2027-2032)
12.1.2 Global Swine Mycoplasma Pneumonia Live Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Swine Mycoplasma Pneumonia Live Vaccine Forecast by Type (2027-2032)
12.7 Global Swine Mycoplasma Pneumonia Live Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
13.1.3 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
13.3.3 Merck Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 HIPRA
13.4.1 HIPRA Company Information
13.4.2 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
13.4.3 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 HIPRA Main Business Overview
13.4.5 HIPRA Latest Developments
13.5 Ceva Sant? Animale
13.5.1 Ceva Sant? Animale Company Information
13.5.2 Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
13.5.3 Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Ceva Sant? Animale Main Business Overview
13.5.5 Ceva Sant? Animale Latest Developments
13.6 Harbin Pharmaceutical Group
13.6.1 Harbin Pharmaceutical Group Company Information
13.6.2 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
13.6.3 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Harbin Pharmaceutical Group Main Business Overview
13.6.5 Harbin Pharmaceutical Group Latest Developments
13.7 Qilu Animal Health Products
13.7.1 Qilu Animal Health Products Company Information
13.7.2 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
13.7.3 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Qilu Animal Health Products Main Business Overview
13.7.5 Qilu Animal Health Products Latest Developments
13.8 Guangdong Winsun Bio-Pharmaceutical
13.8.1 Guangdong Winsun Bio-Pharmaceutical Company Information
13.8.2 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
13.8.3 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Guangdong Winsun Bio-Pharmaceutical Main Business Overview
13.8.5 Guangdong Winsun Bio-Pharmaceutical Latest Developments
13.9 Jilin HeYuan Bioengineering
13.9.1 Jilin HeYuan Bioengineering Company Information
13.9.2 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
13.9.3 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Jilin HeYuan Bioengineering Main Business Overview
13.9.5 Jilin HeYuan Bioengineering Latest Developments
13.10 Jofunhwa Biotechnology
13.10.1 Jofunhwa Biotechnology Company Information
13.10.2 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
13.10.3 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Jofunhwa Biotechnology Main Business Overview
13.10.5 Jofunhwa Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Swine Mycoplasma Pneumonia Live Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Swine Mycoplasma Pneumonia Live Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 168 Strains
Table 4. Major Players of RM48 Strains
Table 5. Major Players of Other
Table 6. Global Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 7. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Type (2021-2026)
Table 8. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Type (2021-2026) & ($ million)
Table 9. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Type (2021-2026)
Table 10. Global Swine Mycoplasma Pneumonia Live Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Swine Mycoplasma Pneumonia Live Vaccine Sale by Application (2021-2026) & (K Units)
Table 12. Global Swine Mycoplasma Pneumonia Live Vaccine Sale Market Share by Application (2021-2026)
Table 13. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Application (2021-2026) & ($ million)
Table 14. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Application (2021-2026)
Table 15. Global Swine Mycoplasma Pneumonia Live Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Swine Mycoplasma Pneumonia Live Vaccine Sales by Company (2021-2026) & (K Units)
Table 17. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Company (2021-2026)
Table 18. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Company (2021-2026)
Table 20. Global Swine Mycoplasma Pneumonia Live Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Producing Area Distribution and Sales Area
Table 22. Players Swine Mycoplasma Pneumonia Live Vaccine Products Offered
Table 23. Swine Mycoplasma Pneumonia Live Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Swine Mycoplasma Pneumonia Live Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share Geographic Region (2021-2026)
Table 28. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Swine Mycoplasma Pneumonia Live Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Country/Region (2021-2026)
Table 32. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales by Country (2021-2026) & (K Units)
Table 35. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Country (2021-2026)
Table 36. Americas Swine Mycoplasma Pneumonia Live Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 38. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2021-2026) & (K Units)
Table 39. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales by Region (2021-2026) & (K Units)
Table 40. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Region (2021-2026)
Table 41. APAC Swine Mycoplasma Pneumonia Live Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 43. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2021-2026) & (K Units)
Table 44. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales by Country (2021-2026) & (K Units)
Table 45. Europe Swine Mycoplasma Pneumonia Live Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 47. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Swine Mycoplasma Pneumonia Live Vaccine
Table 53. Key Market Challenges & Risks of Swine Mycoplasma Pneumonia Live Vaccine
Table 54. Key Industry Trends of Swine Mycoplasma Pneumonia Live Vaccine
Table 55. Swine Mycoplasma Pneumonia Live Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Swine Mycoplasma Pneumonia Live Vaccine Distributors List
Table 58. Swine Mycoplasma Pneumonia Live Vaccine Customer List
Table 59. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Swine Mycoplasma Pneumonia Live Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Swine Mycoplasma Pneumonia Live Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Swine Mycoplasma Pneumonia Live Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Zoetis Basic Information, Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
Table 75. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Zoetis Main Business
Table 77. Zoetis Latest Developments
Table 78. Boehringer Ingelheim Basic Information, Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
Table 80. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Boehringer Ingelheim Main Business
Table 82. Boehringer Ingelheim Latest Developments
Table 83. Merck Basic Information, Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
Table 85. Merck Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. HIPRA Basic Information, Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
Table 90. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. HIPRA Main Business
Table 92. HIPRA Latest Developments
Table 93. Ceva Sant? Animale Basic Information, Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
Table 95. Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Ceva Sant? Animale Main Business
Table 97. Ceva Sant? Animale Latest Developments
Table 98. Harbin Pharmaceutical Group Basic Information, Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
Table 100. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Harbin Pharmaceutical Group Main Business
Table 102. Harbin Pharmaceutical Group Latest Developments
Table 103. Qilu Animal Health Products Basic Information, Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
Table 105. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Qilu Animal Health Products Main Business
Table 107. Qilu Animal Health Products Latest Developments
Table 108. Guangdong Winsun Bio-Pharmaceutical Basic Information, Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
Table 110. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Guangdong Winsun Bio-Pharmaceutical Main Business
Table 112. Guangdong Winsun Bio-Pharmaceutical Latest Developments
Table 113. Jilin HeYuan Bioengineering Basic Information, Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
Table 115. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Jilin HeYuan Bioengineering Main Business
Table 117. Jilin HeYuan Bioengineering Latest Developments
Table 118. Jofunhwa Biotechnology Basic Information, Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
Table 120. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Jofunhwa Biotechnology Main Business
Table 122. Jofunhwa Biotechnology Latest Developments
Table 1. Swine Mycoplasma Pneumonia Live Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Swine Mycoplasma Pneumonia Live Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 168 Strains
Table 4. Major Players of RM48 Strains
Table 5. Major Players of Other
Table 6. Global Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 7. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Type (2021-2026)
Table 8. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Type (2021-2026) & ($ million)
Table 9. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Type (2021-2026)
Table 10. Global Swine Mycoplasma Pneumonia Live Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Swine Mycoplasma Pneumonia Live Vaccine Sale by Application (2021-2026) & (K Units)
Table 12. Global Swine Mycoplasma Pneumonia Live Vaccine Sale Market Share by Application (2021-2026)
Table 13. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Application (2021-2026) & ($ million)
Table 14. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Application (2021-2026)
Table 15. Global Swine Mycoplasma Pneumonia Live Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Swine Mycoplasma Pneumonia Live Vaccine Sales by Company (2021-2026) & (K Units)
Table 17. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Company (2021-2026)
Table 18. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Company (2021-2026)
Table 20. Global Swine Mycoplasma Pneumonia Live Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Producing Area Distribution and Sales Area
Table 22. Players Swine Mycoplasma Pneumonia Live Vaccine Products Offered
Table 23. Swine Mycoplasma Pneumonia Live Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Swine Mycoplasma Pneumonia Live Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share Geographic Region (2021-2026)
Table 28. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Swine Mycoplasma Pneumonia Live Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Country/Region (2021-2026)
Table 32. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales by Country (2021-2026) & (K Units)
Table 35. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Country (2021-2026)
Table 36. Americas Swine Mycoplasma Pneumonia Live Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 38. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2021-2026) & (K Units)
Table 39. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales by Region (2021-2026) & (K Units)
Table 40. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Region (2021-2026)
Table 41. APAC Swine Mycoplasma Pneumonia Live Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 43. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2021-2026) & (K Units)
Table 44. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales by Country (2021-2026) & (K Units)
Table 45. Europe Swine Mycoplasma Pneumonia Live Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 47. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Swine Mycoplasma Pneumonia Live Vaccine
Table 53. Key Market Challenges & Risks of Swine Mycoplasma Pneumonia Live Vaccine
Table 54. Key Industry Trends of Swine Mycoplasma Pneumonia Live Vaccine
Table 55. Swine Mycoplasma Pneumonia Live Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Swine Mycoplasma Pneumonia Live Vaccine Distributors List
Table 58. Swine Mycoplasma Pneumonia Live Vaccine Customer List
Table 59. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Swine Mycoplasma Pneumonia Live Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Swine Mycoplasma Pneumonia Live Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Swine Mycoplasma Pneumonia Live Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Zoetis Basic Information, Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
Table 75. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Zoetis Main Business
Table 77. Zoetis Latest Developments
Table 78. Boehringer Ingelheim Basic Information, Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
Table 80. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Boehringer Ingelheim Main Business
Table 82. Boehringer Ingelheim Latest Developments
Table 83. Merck Basic Information, Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
Table 85. Merck Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. HIPRA Basic Information, Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
Table 90. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. HIPRA Main Business
Table 92. HIPRA Latest Developments
Table 93. Ceva Sant? Animale Basic Information, Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
Table 95. Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Ceva Sant? Animale Main Business
Table 97. Ceva Sant? Animale Latest Developments
Table 98. Harbin Pharmaceutical Group Basic Information, Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
Table 100. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Harbin Pharmaceutical Group Main Business
Table 102. Harbin Pharmaceutical Group Latest Developments
Table 103. Qilu Animal Health Products Basic Information, Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
Table 105. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Qilu Animal Health Products Main Business
Table 107. Qilu Animal Health Products Latest Developments
Table 108. Guangdong Winsun Bio-Pharmaceutical Basic Information, Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
Table 110. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Guangdong Winsun Bio-Pharmaceutical Main Business
Table 112. Guangdong Winsun Bio-Pharmaceutical Latest Developments
Table 113. Jilin HeYuan Bioengineering Basic Information, Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
Table 115. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Jilin HeYuan Bioengineering Main Business
Table 117. Jilin HeYuan Bioengineering Latest Developments
Table 118. Jofunhwa Biotechnology Basic Information, Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Product Portfolios and Specifications
Table 120. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Jofunhwa Biotechnology Main Business
Table 122. Jofunhwa Biotechnology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Swine Mycoplasma Pneumonia Live Vaccine
Figure 2. Swine Mycoplasma Pneumonia Live Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Swine Mycoplasma Pneumonia Live Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 168 Strains
Figure 12. Product Picture of RM48 Strains
Figure 13. Product Picture of Other
Figure 14. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Type in 2026
Figure 15. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Type (2021-2026)
Figure 16. Swine Mycoplasma Pneumonia Live Vaccine Consumed in Piglets
Figure 17. Global Swine Mycoplasma Pneumonia Live Vaccine Market: Piglets (2021-2026) & (K Units)
Figure 18. Swine Mycoplasma Pneumonia Live Vaccine Consumed in Adult Pigs
Figure 19. Global Swine Mycoplasma Pneumonia Live Vaccine Market: Adult Pigs (2021-2026) & (K Units)
Figure 20. Global Swine Mycoplasma Pneumonia Live Vaccine Sale Market Share by Application (2025)
Figure 21. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Application in 2026
Figure 22. Swine Mycoplasma Pneumonia Live Vaccine Sales by Company in 2026 (K Units)
Figure 23. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Company in 2026
Figure 24. Swine Mycoplasma Pneumonia Live Vaccine Revenue by Company in 2026 ($ millions)
Figure 25. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Company in 2026
Figure 26. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales 2021-2026 (K Units)
Figure 29. Americas Swine Mycoplasma Pneumonia Live Vaccine Revenue 2021-2026 ($ millions)
Figure 30. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales 2021-2026 (K Units)
Figure 31. APAC Swine Mycoplasma Pneumonia Live Vaccine Revenue 2021-2026 ($ millions)
Figure 32. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales 2021-2026 (K Units)
Figure 33. Europe Swine Mycoplasma Pneumonia Live Vaccine Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales 2021-2026 (K Units)
Figure 35. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Revenue 2021-2026 ($ millions)
Figure 36. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Country in 2026
Figure 37. Americas Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Country (2021-2026)
Figure 38. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Type (2021-2026)
Figure 39. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Application (2021-2026)
Figure 40. United States Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Region in 2026
Figure 45. APAC Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Region (2021-2026)
Figure 46. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Type (2021-2026)
Figure 47. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Application (2021-2026)
Figure 48. China Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. India Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Country in 2026
Figure 56. Europe Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Country (2021-2026)
Figure 57. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Type (2021-2026)
Figure 58. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Application (2021-2026)
Figure 59. Germany Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. France Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Application (2021-2026)
Figure 67. Egypt Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Swine Mycoplasma Pneumonia Live Vaccine in 2026
Figure 73. Manufacturing Process Analysis of Swine Mycoplasma Pneumonia Live Vaccine
Figure 74. Industry Chain Structure of Swine Mycoplasma Pneumonia Live Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Forecast by Region (2027-2032)
Figure 77. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Swine Mycoplasma Pneumonia Live Vaccine
Figure 2. Swine Mycoplasma Pneumonia Live Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Swine Mycoplasma Pneumonia Live Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 168 Strains
Figure 12. Product Picture of RM48 Strains
Figure 13. Product Picture of Other
Figure 14. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Type in 2026
Figure 15. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Type (2021-2026)
Figure 16. Swine Mycoplasma Pneumonia Live Vaccine Consumed in Piglets
Figure 17. Global Swine Mycoplasma Pneumonia Live Vaccine Market: Piglets (2021-2026) & (K Units)
Figure 18. Swine Mycoplasma Pneumonia Live Vaccine Consumed in Adult Pigs
Figure 19. Global Swine Mycoplasma Pneumonia Live Vaccine Market: Adult Pigs (2021-2026) & (K Units)
Figure 20. Global Swine Mycoplasma Pneumonia Live Vaccine Sale Market Share by Application (2025)
Figure 21. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Application in 2026
Figure 22. Swine Mycoplasma Pneumonia Live Vaccine Sales by Company in 2026 (K Units)
Figure 23. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Company in 2026
Figure 24. Swine Mycoplasma Pneumonia Live Vaccine Revenue by Company in 2026 ($ millions)
Figure 25. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Company in 2026
Figure 26. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales 2021-2026 (K Units)
Figure 29. Americas Swine Mycoplasma Pneumonia Live Vaccine Revenue 2021-2026 ($ millions)
Figure 30. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales 2021-2026 (K Units)
Figure 31. APAC Swine Mycoplasma Pneumonia Live Vaccine Revenue 2021-2026 ($ millions)
Figure 32. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales 2021-2026 (K Units)
Figure 33. Europe Swine Mycoplasma Pneumonia Live Vaccine Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales 2021-2026 (K Units)
Figure 35. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Revenue 2021-2026 ($ millions)
Figure 36. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Country in 2026
Figure 37. Americas Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Country (2021-2026)
Figure 38. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Type (2021-2026)
Figure 39. Americas Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Application (2021-2026)
Figure 40. United States Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Region in 2026
Figure 45. APAC Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Region (2021-2026)
Figure 46. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Type (2021-2026)
Figure 47. APAC Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Application (2021-2026)
Figure 48. China Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. India Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Country in 2026
Figure 56. Europe Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Country (2021-2026)
Figure 57. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Type (2021-2026)
Figure 58. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Application (2021-2026)
Figure 59. Germany Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. France Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Application (2021-2026)
Figure 67. Egypt Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Swine Mycoplasma Pneumonia Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Swine Mycoplasma Pneumonia Live Vaccine in 2026
Figure 73. Manufacturing Process Analysis of Swine Mycoplasma Pneumonia Live Vaccine
Figure 74. Industry Chain Structure of Swine Mycoplasma Pneumonia Live Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Forecast by Region (2027-2032)
Figure 77. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share Forecast by Application (2027-2032)
